Skip to main navigation Skip to search Skip to main content

Targeting PIM kinase activity significantly augments the efficacy of cytarabine

  • Kevin R. Kelly
  • , Claudia M. Espitia
  • , Pietro Taverna
  • , Gavin Choy
  • , Swaminathan Padmanabhan
  • , Steffan T. Nawrocki
  • , Francis J. Giles
  • , Jennifer S. Carew
  • Institute for Drug Development
  • SuperGen Inc.

Research output: Contribution to a Journal (Peer & Non Peer)Letterpeer-review

21 Citations (Scopus)
Original languageEnglish
Pages (from-to)129-132
Number of pages4
JournalBritish Journal of Haematology
Volume156
Issue number1
DOIs
Publication statusPublished - Jan 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AML
  • Drug resistance
  • Leukaemia therapy
  • New drug development
  • New drugs for leukaemia

Cite this